Literature DB >> 25367470

Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.

Tsuneyuki Oda1, Takashi Ogura2, Hideya Kitamura3, Eri Hagiwara3, Tomohisa Baba3, Yasunori Enomoto3, Tae Iwasawa4, Koji Okudela5, Tamiko Takemura6, Fumikazu Sakai7, Yoshinori Hasegawa8.   

Abstract

BACKGROUND: Pleuroparenchymal fibroelastosis (PPFE) is a rare form of interstitial pneumonia and sometimes coexists with a histologic usual interstitial pneumonia (UIP) pattern. This study aimed to describe the distinct clinical features of PPFE with UIP pattern compared with idiopathic pulmonary fibrosis (IPF).
METHODS: We conducted a retrospective review of the medical records of 110 consecutive patients with IPF with a histologic UIP pattern on surgical lung biopsy specimen. Patients meeting radiologic criteria for the diagnosis of PPFE based on high-resolution CT scan and with a histologic UIP pattern were included.
RESULTS: Nine of eleven patients meeting radiologic criteria for the diagnosis of PPFE were histologically confirmed as having PPFE with UIP pattern. The PPFE with UIP pattern group showed a significantly higher residual volume (1.8 L vs 1.3 L, P < .01), higher Paco2 (44.6 mm Hg vs 41.7 mm Hg, P = .04), and higher complication rate of pneumothorax and pneumomediastinum than the 99 patients with IPF/UIP. The ratio of anteroposterior to transthoracic diameter in patients with PPFE with UIP pattern was significantly lower than that in patients with IPF/UIP (P = .04). Survival time tended to be shorter in patients with PPFE with UIP pattern.
CONCLUSIONS: The results support the view that PPFE with UIP pattern is a disease entity distinct from IPF/UIP and may well be classified as PPFE.

Entities:  

Mesh:

Year:  2014        PMID: 25367470     DOI: 10.1378/chest.13-2866

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

1.  Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.

Authors:  Satish K Madala; Vishwaraj Sontake; Ramakrishna Edukulla; Cynthia R Davidson; Stephanie Schmidt; William D Hardie
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

2.  Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.

Authors:  Hiroki Hayashi; Takahito Nei; Shinji Abe; Yoshinobu Saito; Nariaki Kokuho; Kenichiro Atsumi; Kazue Fujita; Takefumi Saito; Takahiro Tanaka; Akihiko Gemma; Arata Azuma
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Pleuroparenchymal fibroelastosis as a histological background of autoimmune diseases.

Authors:  Yoshiaki Kinoshita; Kentaro Watanabe; Hiroshi Ishii; Hisako Kushima; Makoto Hamasaki; Masaki Fujita; Kazuki Nabeshima
Journal:  Virchows Arch       Date:  2018-10-16       Impact factor: 4.064

4.  Pleuroparenchymal fibroelastosis: report of two cases in Brazil.

Authors:  Paula Silva Gomes; Christina Shiang; Gilberto Szarf; Ester Nei Aparecida Martins Coletta; Carlos Alberto de Castro Pereira
Journal:  J Bras Pneumol       Date:  2017-01-23       Impact factor: 2.624

5.  Pleuroparenchymal Fibroelastosis: A Case Report.

Authors:  Oumayma Haloui; Fatima El Allam; Ouiame Nabou; Afaf Thouil; Hatim Kouismi
Journal:  Cureus       Date:  2022-09-15

6.  Pleuroparenchymal fibroelastosis after allogenic hematopoietic stem cell transplantation: important histological component of late-onset noninfectious pulmonary complication accompanied with recurrent pneumothorax.

Authors:  Takahiro Matsui; Tetsuo Maeda; Toru Kida; Jiro Fujita; Hiromi Tsuji; Eiichi Morii; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2016-06-16       Impact factor: 2.490

7.  Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis.

Authors:  Keishi Sugino; Hiroshige Shimizu; Yasuhiko Nakamura; Takuma Isshiki; Keiko Matsumoto; Sakae Homma
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

Review 8.  The pathogenesis and pathology of idiopathic pleuroparenchymal fibroelastosis.

Authors:  Yoshiaki Kinoshita; Hiroshi Ishii; Kazuki Nabeshima; Kentato Watanabe
Journal:  Histol Histopathol       Date:  2020-12-14       Impact factor: 2.303

9.  Metformin reduces pleural fibroelastosis by inhibition of extracellular matrix production induced by CD90-positive myofibroblasts.

Authors:  Yoichiro Aoshima; Yasunori Enomoto; Atsuki Fukada; Yuki Kurita; Sayomi Matsushima; Shiori Meguro; Isao Kosugi; Hideya Kawasaki; Hiroaki Katsura; Tomoyuki Fujisawa; Noriyuki Enomoto; Yutaro Nakamura; Naoki Inui; Takafumi Suda; Toshihide Iwashita
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 10.  Interstitial lung disease pathology in systemic sclerosis.

Authors:  Kristine E Konopka; Jeffrey L Myers
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-07-17       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.